212 related articles for article (PubMed ID: 21295991)
21. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
23. Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) study: Results of a pilot study.
Habbab LM; Hussain S; Power P; Bashir S; Gao P; Semelhago L; VanHelder T; Parry D; Chu V; Lamy A
J Card Surg; 2019 May; 34(5):305-311. PubMed ID: 30908754
[TBL] [Abstract][Full Text] [Related]
24. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?
Dhawale AA; Shah SA; Sponseller PD; Bastrom T; Neiss G; Yorgova P; Newton PO; Yaszay B; Abel MF; Shufflebarger H; Gabos PG; Dabney KW; Miller F
Spine (Phila Pa 1976); 2012 Apr; 37(9):E549-55. PubMed ID: 22037532
[TBL] [Abstract][Full Text] [Related]
25. [A case of postoperative convulsive seizure following tranexamic acid infusion during aortic valve replacement].
Ichikawa J; Kodaka M; Nishiyama K; Sato N; Kubota S; Nakano K; Komori M
Masui; 2013 Feb; 62(2):186-9. PubMed ID: 23479921
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
[TBL] [Abstract][Full Text] [Related]
27. Tranexamic acid in aortic valve replacement.
Armellin G; Casella S; Guzzinati S; Pasini L; Marcassa A; Giron G
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):331-5. PubMed ID: 11426364
[TBL] [Abstract][Full Text] [Related]
28. [The efficacy and safety of tranexamic acid and epsilon-aminocapronic acid in cardiac surgery under extracorporeal circulation].
Iavorovskiĭ AG; Ziuliaeva TP; Charnaia MA; Morozov IuA; Tolstova IA; Gladysheva VG; Buniatian AA
Anesteziol Reanimatol; 2009; (4):10-5. PubMed ID: 19824410
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of low dose tranexamic acid in primary cardiac surgery.
Lambert W; Brisebois FJ; Wharton TJ; Carrier RC; Boyle D; Rowe BH
Can J Anaesth; 1998 Jun; 45(6):571-4. PubMed ID: 9669014
[TBL] [Abstract][Full Text] [Related]
30. Aortic valve replacement in octogenarians: risk factors for early and late mortality.
Melby SJ; Zierer A; Kaiser SP; Guthrie TJ; Keune JD; Schuessler RB; Pasque MK; Lawton JS; Moazami N; Moon MR; Damiano RJ
Ann Thorac Surg; 2007 May; 83(5):1651-6; discussion 1656-7. PubMed ID: 17462374
[TBL] [Abstract][Full Text] [Related]
31. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
33. Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.
Blanié A; Bellamy L; Rhayem Y; Flaujac C; Samama CM; Fontenay M; Rosencher N
Thromb Res; 2013 Jan; 131(1):e6-e11. PubMed ID: 23195143
[TBL] [Abstract][Full Text] [Related]
34. The effect of aprotinin on outcome after coronary-artery bypass grafting.
Shaw AD; Stafford-Smith M; White WD; Phillips-Bute B; Swaminathan M; Milano C; Welsby IJ; Aronson S; Mathew JP; Peterson ED; Newman MF
N Engl J Med; 2008 Feb; 358(8):784-93. PubMed ID: 18287601
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
Shapiro F; Zurakowski D; Sethna NF
Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
[TBL] [Abstract][Full Text] [Related]
36. The risk associated with aprotinin in cardiac surgery.
Mangano DT; Tudor IC; Dietzel C; ;
N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
[TBL] [Abstract][Full Text] [Related]
37. Combined coronary artery bypass grafting and aortic valve replacement with minimal extracorporeal closed circuit circulation versus standard cardiopulmonary bypass.
Yilmaz A; Sjatskig J; van Boven WJ; Waanders FG; Kelder JC; Sonker U; Kloppenburg GT
Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):754-7. PubMed ID: 20847068
[TBL] [Abstract][Full Text] [Related]
38. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Wind TC; Barfield WR; Moskal JT
J Arthroplasty; 2014 Feb; 29(2):387-9. PubMed ID: 23790499
[TBL] [Abstract][Full Text] [Related]
39. Tranexamic acid therapy in pediatric cardiac surgery: a single-center study.
Giordano R; Palma G; Poli V; Palumbo S; Russolillo V; Cioffi S; Mucerino M; Mannacio VA; Vosa C
Ann Thorac Surg; 2012 Oct; 94(4):1302-6. PubMed ID: 22819471
[TBL] [Abstract][Full Text] [Related]
40. Does patient-prosthesis mismatch influence the results of combined aortic valve replacement and coronary bypass grafting?
Mrówczyński W; Lutter G; Attmann T; Hoffmann G; Quaden R; Cremer J; Böning A
Kardiol Pol; 2009 Aug; 67(8):865-73. PubMed ID: 19784883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
